Rani Therapeutics Holdings Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -83.3% | -100.0% | – | – | +16.9% | +0.0% | – | |
| – | -52.5% | +9.3% | +2.8% | +1.6% | +2.7% | – | – | -7.1% | -16.6% | -13.4% | – | – | |
| – | – | -109.8% | – | – | – | -83.3% | -239.5% | – | – | +5.9% | +10.4% | – | |
| – | -32.2% | -0.3% | -19.4% | +0.9% | +10.3% | -3.5% | -16.2% | -41.5% | +52.4% | +5.1% | -2.8% | – | |
| – | -12.2% | +10.6% | -0.6% | -12.2% | -2.9% | +2.8% | -11.0% | -19.3% | +26.0% | -4.0% | +13.0% | – | |
| – | -24.8% | +2.6% | -9.2% | -5.8% | +35.5% | -23.8% | -13.8% | -30.9% | +37.7% | -1.1% | +6.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.5% | -0.2% | -1.4% | +4.8% | -15.9% | -16.1% | -7.0% | -17.3% | -52.1% | -74.6% | -90.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.